Improving Cardiac Rehabilitation Participation in Women and Men

Sponsor
Lawson Health Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT00336830
Collaborator
Canadian Institutes of Health Research (CIHR) (Other), AstraZeneca (Industry)
1,035
1
2
79
13.1

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the effect of a pre-discharge written personal endorsement to the patient by the patient's attending cardiologist or cardiac surgeon (MD endorsement) to take part in the Cardiac Rehabilitation and Secondary Prevention (CR) program, in addition to the standard CR referral, compared to the standard CR referral alone, on CR program enrollment within 2 months of index hospital discharge following admission for myocardial infarction, unstable angina, coronary angioplasty, or coronary artery bypass.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: MD-endorsed Cardiac Rehabilitation referral
  • Behavioral: Standard Cardiac Rehabilitation referral
Phase 3

Detailed Description

There is compelling evidence that a comprehensive CR program comprising the delivery of lifestyle modifying education will reduce mortality, morbidity and improve quality of life in patients following myocardial infarction, angioplasty or, coronary artery bypass. However, less than 20% of eligible patients participate in CR programs. This study will look at a method of potentially improving enrollment and adherence to a CR program. It is expected that patients who receive the MD-endorsed referral will be more likely to attend the initial Orientation appointment and more closely adhere to the 6-month comprehensive CR program, as compared to the patients who receive a standard CR referral alone.

Study Design

Study Type:
Interventional
Actual Enrollment :
1035 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Official Title:
Improving Cardiac Rehabilitation Participation in Women and Men
Study Start Date :
May 1, 2003
Actual Primary Completion Date :
Jun 1, 2007
Actual Study Completion Date :
Dec 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Usual Care

Comparator without MD endorsement of Cardiac Rehabilitation

Behavioral: Standard Cardiac Rehabilitation referral
Note to patient with general description of the Cardiac Rehabilitation program without signature or recommendation from attending physician.
Other Names:
  • Standard Referral to Cardiac Rehabilitation
  • Experimental: MD Endorsment of CR

    Provided with MD endorsement of participation in Cardiac Rehabilitation

    Behavioral: MD-endorsed Cardiac Rehabilitation referral
    Note to patient with general description of the Cardiac Rehabilitation program with signature and strong recommendation from attending physician.
    Other Names:
  • MD endorsed referral to Cardiac Rehabilitation
  • Outcome Measures

    Primary Outcome Measures

    1. Attendance at initial CR orientation appointment within 2 months of index hospital discharge [3 months]

    Secondary Outcome Measures

    1. Impact of MD endorsement on number of patients attending CR program [3 months]

    2. Number of patients who continue to adhere to the 6-month CR program beyond the initial CR orientation appointment [8 months]

    3. Impact of other patient variables and how they influence participation in a CR program [8 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patient is admitted to hospital for myocardial infarction (MI), unstable angina (UA), percutaneous transluminal coronary angioplasty (PTCA), or coronary artery bypass surgery (CABS)

    • Patient resides within 1 hour driving time from London

    Exclusion Criteria:
    • Inability to provide written informed consent or complete survey due to language or cognitive difficulties

    • Previous cardiac rehabilitation participation

    • Patient scheduled to undergo PTCA or CABS within two months following the index hospital discharge

    • Inability to exercise due to musculoskeletal problems or previous or current stroke

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 London Health Sciences Centre London Ontario Canada N6A 5A5

    Sponsors and Collaborators

    • Lawson Health Research Institute
    • Canadian Institutes of Health Research (CIHR)
    • AstraZeneca

    Investigators

    • Principal Investigator: Neville Suskin, MBChB, MSc, University of Western Ontario & London Health Sciences Centre

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Neville Suskin, Principal Investigator, Lawson Health Research Institute
    ClinicalTrials.gov Identifier:
    NCT00336830
    Other Study ID Numbers:
    • R-02-037
    • CIHR 56926
    First Posted:
    Jun 14, 2006
    Last Update Posted:
    Mar 27, 2014
    Last Verified:
    Mar 1, 2014
    Keywords provided by Neville Suskin, Principal Investigator, Lawson Health Research Institute
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 27, 2014